Document Detail


Circulating IL-8 levels in heart failure patients with and without metabolic syndrome.
MedLine Citation:
PMID:  19410569     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: It has been suggested that the metabolic syndrome (MetS) is associated with increased risk for heart failure (HF) and progression of HF. However, the underlying mechanisms are unclear. We tested whether the presence of the MetS would be associated with the increased degree of inflammatory state in HF. METHODS: Ninety-one eligible consecutive stable HF patients participated in this cross-sectional study. Anthropometric measurements were carried out and serum concentrations of lipoproteins, apolipoproteins (apoB, apoAI) and high sensitivity C-reactive protein (hsCRP) were measured. The simultaneous measurement of 17 cytokines using bioplex analysis was used. RESULT: Thirty-five subjects (39% of total, 48% of males and 31% of females) were classified as having the MetS in total HF patients. Serum concentrations of apoB (p<0.005) were significantly higher and the ratio of apoAI and apoB was significantly lower (p<0.01) in HF patients with MetS than those without MetS. Plasma levels of IL-8 (p<0.05) were significantly higher in HF patients with MetS than those without MetS. In addition, serum concentrations of hsCRP (p<0.005) were significantly higher in HF patients with MetS compared to those without MetS. CONCLUSIONS: The MetS in HF is associated with increased degree of inflammation, which provides information regarding the relationship between inflammation and HF with MetS.
Authors:
Min-Jeong Shin; Kyung Hye Lee; Ji Hyung Chung; Yoo Kyoung Park; Mi Kyung Choi; Jaewon Oh; Ji Won Choi; Sang-Hak Lee; Namsik Chung; Seok-Min Kang
Related Documents :
10841219 - The use of subcutaneous erythropoietin and intravenous iron for the treatment of the an...
1599659 - Acute congestive heart failure: pharmacologic intervention.
10385769 - Insights into the contemporary epidemiology and outpatient management of congestive hea...
7428269 - Hypernephroma embolisation--is it worthwhile?
16783489 - Is there a role of the thr164ile-beta(2)-adrenoceptor polymorphism for the outcome of c...
15158299 - Correction of anemia in patients with congestive heart failure increases resting energy...
15542519 - Clinical and subclinical intestinal inflammation assessed by the mucosal patch techniqu...
21973089 - Quantitative real-time pcr and the (1→3)-β-d-glucan assay for differentiation betwee...
22445849 - Multiple antibiotic-resistant pseudomonas aeruginosa and lung function decline in patie...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-05-03
Journal Detail:
Title:  Clinica chimica acta; international journal of clinical chemistry     Volume:  405     ISSN:  1873-3492     ISO Abbreviation:  Clin. Chim. Acta     Publication Date:  2009 Jul 
Date Detail:
Created Date:  2009-06-02     Completed Date:  2009-07-27     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  1302422     Medline TA:  Clin Chim Acta     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  139-42     Citation Subset:  IM    
Affiliation:
Department of Food and Nutrition, Korea University, Seoul, Republic of Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Blood Glucose / metabolism
C-Reactive Protein / metabolism
Female
Heart Failure / blood*,  complications*
Humans
Interleukin-8 / blood*
Lipoproteins / blood
Male
Metabolic Syndrome X / blood*,  complications*
Middle Aged
Chemical
Reg. No./Substance:
0/Blood Glucose; 0/Interleukin-8; 0/Lipoproteins; 9007-41-4/C-Reactive Protein

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Thyroid autoimmunity and thyroid hormone reference intervals in apparently healthy Chinese adults.
Next Document:  Analyses of transthyretin concentration in the cerebrospinal fluid of patients with Guillain-Barré ...